| Entry |
|
|---|
| Name |
Aspirin aluminum (JP18) |
|---|
| Formula |
(C9H7O4)2. Al. OH
|
|---|
| Exact mass |
402.0531
|
|---|
| Mol weight |
402.29
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
|
|---|
| Remark |
| Product (DG00015): | D00109<JP> |
|
|---|
| Efficacy |
Analgesic, COX inhibitor |
|---|
| Comment |
Salicylic acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A01 STOMATOLOGICAL PREPARATIONS
A01A STOMATOLOGICAL PREPARATIONS
A01AD Other agents for local oral treatment
A01AD05 Acetylsalicylic acid
D05181 Aspirin aluminum (JP18)
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC06 Acetylsalicylic acid
D05181 Aspirin aluminum (JP18)
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BA Salicylic acid and derivatives
N02BA01 Acetylsalicylic acid
D05181 Aspirin aluminum (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for nervous and sensory systems
01 Cold remedy (oral use)
D05181 Aspirin aluminum (JP18)
03 Antipyretic analgesic agents
D05181 Aspirin aluminum (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Aspirin
D05181 Aspirin aluminum (JP18)
Second-class OTC drugs
Inorganic and organic chemicals
Aspirin
D05181 Aspirin aluminum (JP18)
Animal drugs in Japan [BR:br08331]
91 Agents affecting nervous system
913 Antipyretics, analgesics and antiinflammatory
9131 Salicylic acids, derivatives and preparations
D05181 Aspirin aluminum
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00015 Acetylsalicylic acid
D05181 Aspirin aluminum
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00015 Acetylsalicylic acid
D05181 Aspirin aluminum
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D05181 Aspirin aluminum (JP18)
PTGS2 (COX2)
D05181 Aspirin aluminum (JP18)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D05181 Aspirin aluminum
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00015 Acetylsalicylic acid
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00015 Acetylsalicylic acid
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 O0 O 29.8220 -21.0720 #-
2 C6a C 25.5515 -18.9018
3 O6a O 26.9517 -18.9018 #-
4 O6a O 27.9318 -21.2821
5 C7a C 26.9517 -22.2622
6 O7a O 25.5515 -22.2622
7 C8y C 24.5714 -21.2821
8 C8y C 24.5714 -19.8819
9 O6a O 24.9915 -17.6417
10 C1a C 27.4417 -23.5923
11 C8x C 23.3113 -19.1818
12 C8x C 22.1212 -19.8819
13 C8x C 22.1212 -21.2821
14 C8x C 23.3113 -21.9821
15 C6a C 33.6024 -20.6520
16 O6a O 32.2023 -20.6520 #-
17 O6a O 31.2221 -18.2717
18 C7a C 32.2023 -17.2916
19 O7a O 33.6024 -17.2916
20 C8y C 34.5825 -18.2717
21 C8y C 34.5825 -19.6719
22 O6a O 34.1625 -21.9121
23 C1a C 31.7122 -15.9615
24 C8x C 35.8426 -20.3720
25 C8x C 37.0328 -19.6719
26 C8x C 37.0328 -18.2717
27 C8x C 35.8426 -17.5717
28 Z Al 28.9819 -19.4619 #3+
BOND 26
1 2 3 1
2 4 5 2
3 5 6 1
4 6 7 1
5 7 8 1
6 8 2 1
7 2 9 2
8 5 10 1
9 8 11 2
10 11 12 1
11 12 13 2
12 13 14 1
13 7 14 2
14 15 16 1
15 17 18 2
16 18 19 1
17 19 20 1
18 20 21 1
19 21 15 1
20 15 22 2
21 18 23 1
22 21 24 2
23 24 25 1
24 25 26 2
25 26 27 1
26 20 27 2
|
|---|